Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 2360Neoplasms 1709Prostatic Neoplasms 1201Lung Neoplasms 926Colorectal Neoplasms 886Carcinoma, Non-Small-Cell Lung 869Leukemia, Myeloid, Acute 593Pancreatic Neoplasms 578Multiple Myeloma 551Carcinoma, Hepatocellular 518Brain Neoplasms 516Neoplasm Metastasis 462Head and Neck Neoplasms 458Melanoma 417Ovarian Neoplasms 414Glioblastoma 403Precursor Cell Lymphoblastic Leukemia-Lymphoma 400Stomach Neoplasms 377Uterine Cervical Neoplasms 365Squamous Cell Carcinoma of Head and Neck 362Rectal Neoplasms 342Recurrence 337Sarcoma 327Hematologic Neoplasms 324Colonic Neoplasms 323Lymphoma 321Triple Negative Breast Neoplasms 291Carcinoma, Renal Cell 284Glioma 283Urinary Bladder Neoplasms 281

Interventions

Multiparametric Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Urothelial Bladder Cancer × 1 year × Clear all
NCT06335667 2026-05-04

mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer

University of California, Irvine

Phase NA Recruiting
30 enrolled
Genitourinary

Urothelial Bladder Cancer

NCT04428554 2025-11-18

BLAD-RAD01

Institut Claudius Regaud

Phase 2 Recruiting
130 enrolled
Genitourinary

Urothelial Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡